209 related articles for article (PubMed ID: 8101692)
1. Combined use of esmolol and digoxin in the acute treatment of atrial fibrillation or flutter.
Shettigar UR; Toole JG; Appunn DO
Am Heart J; 1993 Aug; 126(2):368-74. PubMed ID: 8101692
[TBL] [Abstract][Full Text] [Related]
2. Esmolol: a new ultrashort-acting beta-adrenergic blocking agent for rapid control of heart rate in postoperative supraventricular tachyarrhythmias.
Gray RJ; Bateman TM; Czer LS; Conklin CM; Matloff JM
J Am Coll Cardiol; 1985 Jun; 5(6):1451-6. PubMed ID: 2860148
[TBL] [Abstract][Full Text] [Related]
3. Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter.
Platia EV; Michelson EL; Porterfield JK; Das G
Am J Cardiol; 1989 Apr; 63(13):925-9. PubMed ID: 2564725
[TBL] [Abstract][Full Text] [Related]
4. Esmolol: safety and efficacy in postoperative cardiothoracic patients with supraventricular tachyarrhythmias.
Schwartz M; Michelson EL; Sawin HS; MacVaugh H
Chest; 1988 Apr; 93(4):705-11. PubMed ID: 2894920
[TBL] [Abstract][Full Text] [Related]
5. Esmolol versus diltiazem in the treatment of postoperative atrial fibrillation/atrial flutter after open heart surgery.
Mooss AN; Wurdeman RL; Mohiuddin SM; Reyes AP; Sugimoto JT; Scott W; Hilleman DE; Seyedroudbari A
Am Heart J; 2000 Jul; 140(1):176-80. PubMed ID: 10874282
[TBL] [Abstract][Full Text] [Related]
6. Emergency management of atrial fibrillation and flutter: intravenous diltiazem versus intravenous digoxin.
Schreck DM; Rivera AR; Tricarico VJ
Ann Emerg Med; 1997 Jan; 29(1):135-40. PubMed ID: 8998092
[TBL] [Abstract][Full Text] [Related]
7. Clinical decision analysis modeling: short-term control of ventricular response rate in atrial fibrillation or atrial flutter-digoxin versus diltiazem.
Gonzalez ER; Ornato JP; Lawson CL
Pharmacotherapy; 1994; 14(4):446-51. PubMed ID: 7937281
[TBL] [Abstract][Full Text] [Related]
8. Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
Sethi NJ; Nielsen EE; Safi S; Feinberg J; Gluud C; Jakobsen JC
PLoS One; 2018; 13(3):e0193924. PubMed ID: 29518134
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of esmolol (ASL-8052: an ultrashort-acting beta-adrenergic blocking agent) for control of ventricular rate in supraventricular tachycardias.
Byrd RC; Sung RJ; Marks J; Parmley WW
J Am Coll Cardiol; 1984 Feb; 3(2 Pt 1):394-9. PubMed ID: 6141193
[TBL] [Abstract][Full Text] [Related]
10. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacologic restoration of sinus rhythm in atrial flutter and fibrillation].
Vainer J; Smíd J; Cepeláková H; Hapala J; Topinka I; Topolcan O
Vnitr Lek; 1989 Feb; 35(2):145-50. PubMed ID: 2711622
[TBL] [Abstract][Full Text] [Related]
12. [Successful control of rapid heart rate with atrial flutter by intravenous administration of esmolol in a patient after total correction of the tetralogy of Fallot].
Masamune T; Suzuki S; Nonaka A; Imamura M; Abe F
Masui; 2004 Aug; 53(8):918-20. PubMed ID: 15446684
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and costs of digoxin treatment for atrial fibrillation and flutter.
Roberts SA; Diaz C; Nolan PE; Salerno DM; Stapczynski JS; Zbrozek AS; Ritz EG; Bauman JL; Vlasses PH
Am J Cardiol; 1993 Sep; 72(7):567-73. PubMed ID: 8362772
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of flestolol, a new ultrashort-acting beta-adrenergic blocking agent, for supraventricular tachyarrhythmias.
Steinberg JS; Katz RJ; Somberg JC; Keefe D; Laddu AR; Burge J
Am J Cardiol; 1986 Nov; 58(10):1005-8. PubMed ID: 2877563
[TBL] [Abstract][Full Text] [Related]
15. Effects of nadolol on the spontaneous and exercise-provoked heart rate of patients with chronic atrial fibrillation receiving stable dosages of digoxin.
DiBianco R; Morganroth J; Freitag JA; Ronan JA; Lindgren KM; Donohue DJ; Larca LJ; Chadda KD; Olukotun AY
Am Heart J; 1984 Oct; 108(4 Pt 2):1121-7. PubMed ID: 6148872
[TBL] [Abstract][Full Text] [Related]
16. [A comparative study on the efficacy and safety of intravenous esmolol, amiodarone and diltiazem for controlling rapid ventricular rate of patients with atrial fibrillation during anesthesia period].
Shen SL; Zhao YC
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Nov; 38(11):989-92. PubMed ID: 21215227
[TBL] [Abstract][Full Text] [Related]
17. The effect of carvedilol on B-type natriuretic peptide and cardiac function in patients with heart failure and persistent atrial fibrillation.
Khand AU; Chew PG; Douglas H; Jones J; Jan A; Cleland JG
Cardiology; 2015; 130(3):153-8. PubMed ID: 25660493
[TBL] [Abstract][Full Text] [Related]
18. Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomized, digoxin-controlled study.
Hou ZY; Chang MS; Chen CY; Tu MS; Lin SL; Chiang HT; Woosley RL
Eur Heart J; 1995 Apr; 16(4):521-8. PubMed ID: 7671898
[TBL] [Abstract][Full Text] [Related]
19. Beta-adrenergic blockade accelerates conversion of postoperative supraventricular tachyarrhythmias.
Balser JR; Martinez EA; Winters BD; Perdue PW; Clarke AW; Huang W; Tomaselli GF; Dorman T; Campbell K; Lipsett P; Breslow MJ; Rosenfeld BA
Anesthesiology; 1998 Nov; 89(5):1052-9. PubMed ID: 9821992
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of efficacy and safety of low-dose diltiazem or betaxolol in combination with digoxin to control ventricular rate in chronic atrial fibrillation: randomized crossover study.
Koh KK; Song JH; Kwon KS; Park HB; Baik SH; Park YS; In HH; Moon TH; Park GS; Cho SK
Int J Cardiol; 1995 Nov; 52(2):167-74. PubMed ID: 8749878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
